The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C
✍ Scribed by Kathleen B. Schwarz; Regino P. Gonzalez–Peralta; Karen F. Murray; Jean P. Molleston; Barbara A. Haber; Maureen M. Jonas; Philip Rosenthal; Parvathi Mohan; William F. Balistreri; Michael R. Narkewicz; Lesley Smith; Steven J. Lobritto; Stephen Rossi; Alexandra Valsamakis; Zachary Goodman; Patricia R. Robuck; Bruce A. Barton
- Book ID
- 119761767
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 987 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Peginterferon plus ribavirin is standard therapy for adults with chronic hepatitis C. As no data are available for children, the aim of the study was to evaluate the efficacy and tolerability of peginterferon alfa-2b in combination with ribavirin in chronically infected children. Genotypes, alanine